Nukepills, Inc. manages the Internet sales and marketing division for Anbex, the U.S.-based manufacturer of Iosat™ Potassium Iodide. We also operate and manage Anbex’s worldwide wholesale distribution facility based in Maryland. Nukepills.com was founded in 1999 as a means of supplying Nuclear, Biological and Chemical protection products directly to the general public and now has international sales programs throughout Canada, Europe, Asia and the Middle East. Nukepills is a major supplier to pharmacies, hospitals, nuclear facilities, other web-based distributors and local/state/federal governments within the U.S. and worldwide. In 2009, Nukepills.com sold 5.4 million doses of FDA-Approved Potassium Iodide (Liquid KI) to Kuwait’s Ministry of Health. In 2011, Nukepills.com donated 108,000 pediatric doses of potassium iodide to Japan after the Fukushima Daiichi nuclear reactor disaster. Government Emergency Preparedness grants and civilian orders are expected to continue to drive sales well into 2023.
Radiation Protection Supplies and Information — Water Filtration Supplies and Information
What Is Potassium Iodide?
Stockpiling of potassium iodide (KI) is highly recommended by health officials worldwide to prevent thyroid cancer of those exposed to radioactive iodine following a nuclear reactor accident or detonation of a nuclear weapon. Radioactive iodine can travel hundreds of miles downwind, such as it did after the Chernobyl and Fukushima disasters.
How Potassium Iodide Works
The thyroid is the only part of the body that absorbs and stores iodine. By taking FDA approved potassium iodide prior to exposure of radioactive iodine, your thyroid will become saturated with safe, stable iodine. This will prevent your thyroid’s absorption of any additional iodine (radioactive or not) long enough for the radioactive iodine inhaled or ingested to be safely dispersed through the kidneys.
6 Million Potassium Iodide Tablets Delivered to U.S. Dept. of HHS
Mooresville, NC – May 13, 2014 – Nukepills.com announces today that the U.S. Department of Health and Human Services (HHS) was recently shipped 6,383,000 tablets of FDA approved potassium iodide for protection against radiation in the event of a nuclear reactor accident. The balance of the total 14 million tablet solicitation by HHS, on behalf of the Nuclear Regulatory Commission (NRC), is scheduled for delivery by the end of 2014… Read Full Press Release
54,000 potassium iodide pills donated to Japan for nuclear radiation exposure
Approximately 54,000 potassium iodide tablets have been donated by Nukepills.com to Tokushukai Hospital in Tokyo, Japan for immediate distribution to those affected by Japan’s nuclear reactor crisis. …. “We are very pleased that these tablets will be given to people directly affected by the nuclear crisis”, stated Troy Jones, President of Nukepills.com… Read Full Press Release
Kuwait purchases 5.4M doses of emergency nuclear radiation drug from Nukepills.com
Nukepills.com today announced the sale of 180,000 units (5.4 million doses) of ThyroShield™ Potassium Iodide to the Kuwait Ministry of Health. Worth approximately $1.4 million, the sale was brokered by Nukepills.com and signifies Kuwait’s proactive course in protecting its citizens during a nuclear radiation emergency… Read Full Press Release